CEFUROXIME Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cefuroxime, and when can generic versions of Cefuroxime launch?
Cefuroxime is a drug marketed by B Braun, Sun Pharm Inds Ltd, Alkem Labs Ltd, Anda Repository, Ani Pharms, Apotex, Aurobindo Pharma, Chartwell Rx, Fosun Pharma, Lupin, Ranbaxy Labs Ltd, Acs Dobfar Spa, Fresenius Kabi Usa, Hikma, Hospira Inc, Teva Pharms, Watson Labs Inc, and Samson Medcl. and is included in twenty-six NDAs.
The generic ingredient in CEFUROXIME is cefuroxime axetil. There are sixty-two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cefuroxime
A generic version of CEFUROXIME was approved as cefuroxime axetil by APOTEX on October 2nd, 2002.
Summary for CEFUROXIME
US Patents: | 0 |
Applicants: | 18 |
NDAs: | 26 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for CEFUROXIME |
Drug Sales Revenues: | Drug sales revenues for CEFUROXIME |
DailyMed Link: | CEFUROXIME at DailyMed |
Pharmacology for CEFUROXIME
Drug Class | Cephalosporin Antibacterial |